Skip to Content

Tesamorelin

In the US, Tesamorelin (tesamorelin systemic) is a member of the drug class growth hormones and is used to treat Lipodystrophy.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H01AC06

CAS registry number (Chemical Abstracts Service)

0218949-48-5

Chemical Formula

C221-H366-N72-O67-S

Molecular Weight

5135

Therapeutic Category

Hypothalamic hormone: Growth hormone releasing hormone, GHRH

Chemical Name

(3E)-hex-3-enoylsomatoliberin (human GHRH) (WHO )

Foreign Names

  • Tesamorelinum (Latin)
  • Tesamorelin (German)
  • TesamorĂ©line (French)
  • Tesamorelina (Spanish)

Generic Names

  • Tesamorelin (OS: USAN)
  • eh-GRIF-tuh (IS)
  • TH9507 (IS)
  • UNII-MQG94M5EEO (IS)
  • Tesamorelin Acetate (OS: USAN)

Brand Name

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide